{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:55:00Z","timestamp":1791006900135,"version":"4.1.0"},"reference-count":16,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.26017","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:10:57Z","timestamp":1785363057000},"page":"209-216","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Pola-R-CHP and R-CHOP for newly diagnosed DLBCL: A single-center retrospective study"],"prefix":"10.3960","volume":"66","author":[{"given":"Kaori","family":"Akita","sequence":"first","affiliation":[{"name":"Department of Hematology, Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takahata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Tokuyama","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokai university school of medicine, Isehara, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Toyota","sequence":"additional","affiliation":[{"name":"Department of Hematology, Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Swerdlow SH, Campo E, Harris NL, <i>et al.<\/i>: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed, Lyon, IARC. 2017."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Coiffier B, Lepage E, Briere J <i>et al.<\/i> CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346: 235-242.","DOI":"10.1056\/NEJMoa011795"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Coiffier B, Thieblemont C, Van Den Neste E <i>et al.<\/i> Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte. Blood. 2010; 116: 2040-2045.","DOI":"10.1182\/blood-2010-03-276246"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Tilly H, Morschhauser F, Sehn LH <i>et al.<\/i> Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med. 2022; 386: 351-363.","DOI":"10.1056\/NEJMoa2115304"},{"key":"5","unstructured":"5 Swerdlow SH, Campo E, Harris NL, <i>et al.<\/i>: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC. 2008."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hans CP, Weisenburger DD, Greiner TC <i>et al.<\/i> Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103: 275-282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Davies AJ. The high-grade B-cell lymphomas: double hit and more. Blood. 2024; 144: 2583-2592.","DOI":"10.1182\/blood.2023020780"},{"key":"8","unstructured":"8 National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Bethesda, MD, National Cancer Institute. 2017."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013; 48: 452-458.","DOI":"10.1038\/bmt.2012.244"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Eyre TA, Martinez-Calle N, Hildyard C <i>et al.<\/i> Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age. J Intern Med. 2019; 285: 681-692.","DOI":"10.1111\/joim.12889"},{"key":"11","unstructured":"11 Yhim HY. Treatment of elderly patients with diffuse large B-cell lymphoma. Korean J Intern Med. 2024; 39: 47-59."},{"key":"12","unstructured":"12 Sapkota S, Poudel A, Giri S <i>et al.<\/i> Association of geriatric assessment with outcomes in older adults with diffuse large B-cell lymphoma receiving R-CHOP. J Geriatr Oncol. 2022; 13: 1164-1171."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Tucci A, Martelli M, Rigacci L <i>et al.<\/i> Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL). Br J Haematol. 2015; 168: 839-847.","DOI":"10.3109\/10428194.2014.953142"},{"key":"14","unstructured":"14 Spina M, Balzarotti M, Uziel L <i>et al.<\/i> Evaluation of older patients with lymphoma: a systematic review. Hematol Oncol Clin North Am. 2016; 30: 1179-1191."},{"key":"15","unstructured":"15 Lin RJ, Behera M, Diefenbach CS <i>et al.<\/i> Geriatric assessment-guided treatment for older adults with diffuse large B-cell lymphoma. J Natl Compr Canc Netw. 2023; 21: 51-60."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Compagno N, Malipiero G, Cinetto F, Agostini C. Immunoglobulin replacement therapy in secondary hypogammaglobulinemia. Front Immunol. 2014; 5: 626.","DOI":"10.3389\/fimmu.2014.00626"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/3\/66_26017\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:34:54Z","timestamp":1791005694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/3\/66_26017\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.26017","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26017"}}